Guatemala Medical Device Registration: NT 37 Article 5 Document Checklist

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The document checklist for the sanitary registration of medical devices in Guatemala is set out in Article 5.1 of NT 37 Versión 5-2016 and comprises thirteen items: proof of payment of the registration fee, application form F-AS-f-08, finished product specifications, product description, certificate of free sale, good manufacturing practices certificate, authenticated photocopy of the manufacturer’s letter of authorisation, analytical methods, quality control certificate, original packaging or readable mock-up, sealed samples, technical literature or package insert, and a photocopy of the sanitary licence of the registration holder. The dossier must be submitted in a natural-colour ring binder folder, and three of the thirteen items are marked as submitted only when applicable. Understanding the full list, its internal order and its conditional entries is the foundation of every well-built Guatemalan dossier, because a formal review at the window will check the dossier against this list item by item before any technical assessment begins.

  • Thirteen items are listed under Article 5.1, and each carries its own sub-clause number.
  • The payment voucher is the first item, and the fee expressly includes sanitary surveillance.
  • The finished product specifications and the product description must both be in Spanish.
  • The letter of authorisation requires an authenticated photocopy; the sanitary licence requires only a simple photocopy.
  • Packaging must be the original or a readable mock-up — photocopies and overlaid labels are not accepted.
  • Analytical methods, sealed samples and technical literature are the three items qualified by “cuando aplique”, meaning when applicable.

2. Legal basis

The table below reproduces the thirteen-item checklist of Article 5.1 in the order fixed by the technical standard, together with the clause that governs each item. Keeping this table as the master index of the dossier is the most reliable way to make sure that nothing is missing when the file reaches the submission window.

Item no.DocumentClause
1Proof of payment of the registration fee (the fee already includes sanitary surveillance)Article 5.1.1
2Application form F-AS-f-08, signed, stamped and emboss-sealed by the chemist-pharmacistArticle 5.1.2
3Finished product specifications, in SpanishArticle 5.1.3
4Product description, in SpanishArticle 5.1.4
5Certificate of free sale issued by the competent health authority of the country of originArticle 5.1.5
6Good manufacturing practices certificate or other equivalent sanitary standardArticle 5.1.6
7Authenticated photocopy of the manufacturer’s letter of authorisationArticle 5.1.7
8Analytical methods (when applicable)Article 5.1.8
9Quality control certificate issued by the manufacturing laboratory, signed and sealed by the responsible professionalArticle 5.1.9
10Original primary and/or secondary packaging or readable mock-up (photocopies and overlaid labels are not accepted)Article 5.1.10
11Sealed samples (according to the LNS quantity list, when applicable)Article 5.1.11
12Product technical literature, catalogue or package insert (Spanish, when applicable)Article 5.1.12
13Simple photocopy of the sanitary licence of the registration holder’s premisesArticle 5.1.13

3. Expert insights

Insight one: the payment voucher is listed first, and the fee includes sanitary surveillance. Article 5.1.1 states that the fee “contempla también la vigilancia sanitaria” — it already covers sanitary surveillance. This means the official fee is not merely the consideration for processing the application; the cost of post-market oversight is built into it from the start. A budgeting model should therefore not treat this payment as a one-off administrative charge that ends once the certificate is issued, but as a contribution that continues to fund the surveillance system throughout the life of the registration. Planning teams that internalise this reading avoid underestimating what the Guatemalan fee actually represents.

Insight two: Article 5.1.10 imposes the strictest formal requirements on packaging. The clause states plainly “No se aceptan fotocopias ni etiquetas sobrepuestas” — photocopies are not accepted, and neither are overlaid labels. This elevates the packaging mock-up from a supporting reference to a formal requisite of the dossier. A submission built on photocopied artwork or on labels stuck onto an existing pack will be rejected at the threshold, before the merits of the product are ever discussed. Preparing genuine originals or properly produced readable mock-ups is therefore not cosmetic diligence; it is a pass-or-fail condition for the entire file.

Insight three: Articles 5.1.7 and 5.1.13 treat photocopies differently. The letter of authorisation requires a “fotocopia autenticada” — an authenticated photocopy — while the sanitary licence of the registration holder needs only a “fotocopia simple”, a simple photocopy. The coexistence of two different photocopy standards within one dossier shows that the authority distinguishes the source of validity of each document. The authorisation comes from a foreign manufacturer abroad, so an authentication step is needed to give it probative force locally; the sanitary licence is issued by a domestic authority and can be verified against official records. Mixing the two standards, either by over-authenticating the licence or by submitting a plain copy of the authorisation, signals unfamiliarity with the checklist.

Insight four: the three “when applicable” clauses are the source of review flexibility. Analytical methods (5.1.8), sealed samples (5.1.11) and technical literature (5.1.12) all carry “cuando aplique”. Whether they apply is strongly linked to the risk class. Annex 1 makes clear that Class I products are exempt from laboratory testing, so sealed samples will typically not apply for Class I; Classes II to IV must be tested, so samples and analytical methods will most likely be required for them. Making an explicit, documented applicability determination for these three items turns a potential source of window queries into a controlled, predictable element of the dossier.

4. Practical recommendations

  • Build a thirteen-item documentation tracker from Article 5.1, recording for each item its status, issuing party, validity period and translation state.
  • Handle the three “when applicable” clauses as separate applicability determinations, and record the reasoning in the dossier file.
  • Prepare packaging exclusively as originals or readable mock-ups, and never submit photocopies or samples carrying overlaid labels.
  • Obtain an authenticated photocopy of the letter of authorisation and a simple photocopy of the sanitary licence, and keep the two standards apart.
  • Assemble the complete dossier in a natural-colour ring binder folder as required by Article 5.1.

5. Verification checklist

  • □ All thirteen items are complete and each is annotated with its current status
  • □ The payment voucher is placed as the first item of the dossier
  • □ The application form carries the signature, stamp and emboss seal in full
  • □ Applicability has been determined for the three “when applicable” items
  • □ Packaging is original or a readable mock-up, with no photocopies or overlaid labels
  • □ The letter of authorisation is an authenticated photocopy and the sanitary licence a simple photocopy
  • □ The dossier is assembled in a natural-colour ring binder folder

Regulatory information verified as of October 29, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail